| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |